Loading…
Sectoral / Thematic · Nippon India Mutual Fund · AMFI code 102431Nippon India Pharma Fund
Disclosed for 84 months, Sep 2019 to Aug 2026.Published as: NIPPON INDIA PHARMA FUND (An Open Ended Equity Scheme Investing In Pharma Sector)
Portfolio value
₹8,352 Cr
up ₹92.6 Cr vs Apr 2025
- Stocks held
- 36
- down 1 vs Apr 2025
- Top 10 weight
- 58.4%
- of the portfolio in its ten largest
- Cash & debt
- 1.4%
- cash, money market and debt
- Moves this month
- 0 in · 1 out
- added to 10, trimmed 12
Nippon India Pharma Fund is an active equity fund in the Sectoral / Thematic category from Nippon India Mutual Fund. In May 2025 it disclosed 36 stocks worth ₹8,352 Cr, up ₹92.6 Cr from Apr 2025. Its largest positions were Sun Pharmaceutical Industries Limited (12.6%), Divi's Laboratories Limited (9.5%), Lupin Limited (5.8%); the ten largest together made up 58.4% of the portfolio, and Pharmaceuticals & Biotechnology was the biggest sector at 75.8% of its equity. Cash and debt stood at 1.4%. Compared with Apr 2025 the fund entered 0 new stocks and exited 1.
Against 226 other Sectoral / Thematic funds
Concentration
80%
Top-10 weight is higher than 80% of peers
Breadth
31%
Holds more stocks than 31% of peers
Cash
21%
Holds more cash than 21% of peers
Holdings in May 2025
Download CSVEvery line the fund disclosed, with the change against Apr 2025. Click a column to sort; click a company to see every fund that owns it.
- Weight
- 12.57%
- Δ weight
- down 1.31 pts
- Value
- ₹1,050 Cr
- Δ value
- down ₹96.8 Cr
- Status
- Trimmed
- Weight
- 9.49%
- Δ weight
- down 0.08 pts
- Value
- ₹793 Cr
- Δ value
- up ₹2.1 Cr
- Status
- Held
- Weight
- 5.82%
- Δ weight
- down 0.48 pts
- Value
- ₹486 Cr
- Δ value
- down ₹34.3 Cr
- Status
- Trimmed
- Weight
- 5.62%
- Δ weight
- down 0.39 pts
- Value
- ₹469 Cr
- Δ value
- down ₹27 Cr
- Status
- Trimmed
- Weight
- 5.49%
- Δ weight
- up 0.24 pts
- Value
- ₹458 Cr
- Δ value
- up ₹24.6 Cr
- Status
- Added
- Weight
- 5.34%
- Δ weight
- down 0.14 pts
- Value
- ₹446 Cr
- Δ value
- down ₹6.3 Cr
- Status
- Trimmed
- Weight
- 4.20%
- Δ weight
- up 0.66 pts
- Value
- ₹351 Cr
- Δ value
- up ₹58.1 Cr
- Status
- Added
- Weight
- 3.73%
- Δ weight
- up 0.10 pts
- Value
- ₹311 Cr
- Δ value
- up ₹11.3 Cr
- Status
- Added
- Weight
- 3.24%
- Δ weight
- down 0.19 pts
- Value
- ₹271 Cr
- Δ value
- down ₹12.5 Cr
- Status
- Trimmed
- Weight
- 2.94%
- Δ weight
- down 0.10 pts
- Value
- ₹245 Cr
- Δ value
- down ₹5.7 Cr
- Status
- Trimmed
- Weight
- 2.91%
- Δ weight
- up 0.32 pts
- Value
- ₹243 Cr
- Δ value
- up ₹28.8 Cr
- Status
- Added
- Weight
- 2.88%
- Δ weight
- down 0.26 pts
- Value
- ₹241 Cr
- Δ value
- down ₹18.7 Cr
- Status
- Trimmed
- Weight
- 2.87%
- Δ weight
- down 0.36 pts
- Value
- ₹240 Cr
- Δ value
- down ₹26.9 Cr
- Status
- Trimmed
- Weight
- 2.37%
- Δ weight
- down 0.01 pts
- Value
- ₹198 Cr
- Δ value
- up ₹1.2 Cr
- Status
- Added
- Weight
- 2.34%
- Δ weight
- down 0.19 pts
- Value
- ₹195 Cr
- Δ value
- down ₹13.8 Cr
- Status
- Trimmed
- Weight
- 2.24%
- Δ weight
- up 0.30 pts
- Value
- ₹187 Cr
- Δ value
- up ₹26.9 Cr
- Status
- Added
- Weight
- 2.23%
- Δ weight
- up 0.08 pts
- Value
- ₹186 Cr
- Δ value
- up ₹8.4 Cr
- Status
- Added
- Weight
- 2.22%
- Δ weight
- up 0.34 pts
- Value
- ₹185 Cr
- Δ value
- up ₹30.2 Cr
- Status
- Added
- Weight
- 2.14%
- Δ weight
- up 0.48 pts
- Value
- ₹179 Cr
- Δ value
- up ₹42 Cr
- Status
- Added
- Weight
- 2.01%
- Δ weight
- up 0.05 pts
- Value
- ₹168 Cr
- Δ value
- up ₹6.4 Cr
- Status
- Added
- Weight
- 1.98%
- Δ weight
- down 0.03 pts
- Value
- ₹165 Cr
- Δ value
- down ₹57 L
- Status
- Held
- Weight
- 1.71%
- Δ weight
- up 0.05 pts
- Value
- ₹143 Cr
- Δ value
- up ₹5.7 Cr
- Status
- Added
- Cash, TREPS & receivables
- Weight
- 1.42%
- Δ weight
- up 1.13 pts
- Value
- ₹119 Cr
- Δ value
- up ₹94.7 Cr
- Status
- Added
- Weight
- 1.40%
- Δ weight
- up 0.19 pts
- Value
- ₹117 Cr
- Δ value
- up ₹17.3 Cr
- Status
- Added
- Weight
- 1.35%
- Δ weight
- up 0.07 pts
- Value
- ₹113 Cr
- Δ value
- up ₹7 Cr
- Status
- Added
- Weight
- 1.34%
- Δ weight
- up 0.01 pts
- Value
- ₹112 Cr
- Δ value
- up ₹1.9 Cr
- Status
- Added
- Weight
- 1.22%
- Δ weight
- up 0.07 pts
- Value
- ₹102 Cr
- Δ value
- up ₹6.9 Cr
- Status
- Added
- Weight
- 1.15%
- Δ weight
- down 0.87 pts
- Value
- ₹96.3 Cr
- Δ value
- down ₹70.9 Cr
- Status
- Trimmed
- Weight
- 0.93%
- Δ weight
- up 0.02 pts
- Value
- ₹78 Cr
- Δ value
- up ₹2.3 Cr
- Status
- Added
- Weight
- 0.92%
- Δ weight
- up 0.03 pts
- Value
- ₹76.7 Cr
- Δ value
- up ₹3.2 Cr
- Status
- Added
- Weight
- 0.87%
- Δ weight
- up 0.01 pts
- Value
- ₹72.7 Cr
- Δ value
- up ₹1.4 Cr
- Status
- Added
- Weight
- 0.75%
- Δ weight
- up 0.38 pts
- Value
- ₹62.5 Cr
- Δ value
- up ₹31.7 Cr
- Status
- Added
- Weight
- 0.61%
- Δ weight
- down 0.06 pts
- Value
- ₹51.1 Cr
- Δ value
- down ₹4.5 Cr
- Status
- Trimmed
- Weight
- 0.57%
- Δ weight
- up 0.37 pts
- Value
- ₹47.6 Cr
- Δ value
- up ₹31.3 Cr
- Status
- Added
- Weight
- 0.55%
- Δ weight
- up 0.03 pts
- Value
- ₹46 Cr
- Δ value
- up ₹3.3 Cr
- Status
- Added
- Weight
- 0.37%
- Δ weight
- down 0.11 pts
- Value
- ₹31 Cr
- Δ value
- down ₹8.5 Cr
- Status
- Trimmed
- Weight
- 0.23%
- Δ weight
- up 0.03 pts
- Value
- ₹19.5 Cr
- Δ value
- up ₹2.6 Cr
- Status
- Added
What changed, Apr 2025 to May 2025
New New positions (0)
None.
Exited Exited (1)
- Krishna Institute Of Medical Sciences Limitedwas 0.4% · ₹30.3 Cr
Added Biggest additions
- MedPlus Health Services Limitedup ₹58.1 Cr (+0.66% pts)
- Pfizer Limitedup ₹42 Cr (+0.48% pts)
- Emcure Pharmaceuticals Limitedup ₹31.7 Cr (+0.38% pts)
- Akums Drugs and Pharmaceuticals Limitedup ₹31.3 Cr (+0.37% pts)
Sectors
Which sectors the fund is moving towards and away from, and where its money sits now. Shares are of the fund’s classified equity holdings, so they add up to 100%.
Where the weight moved
Compared with
Since Apr 2025, the weight rose most in Retailing (+0.7 pts), and fell most in Pharmaceuticals & Biotechnology (−0.6 pts) and Healthcare Services (−0.1 pts).
- Retailing3.6% → 4.3%+0.7 pts
- Pharmaceuticals & Biotechnology76.4% → 75.8%−0.6 pts
- Healthcare Services19.6% → 19.4%−0.1 pts
A sector’s weight changes when the fund buys or sells, and also when its shares rise or fall in price, so a change is not by itself a sign of buying or selling.
Main sectors’ weights over time
| Sector | May 2022 | May 2024 | Nov 2024 | Feb 2025 | Apr 2025 | May 2025 |
|---|---|---|---|---|---|---|
| Pharmaceuticals & Biotechnology | 79.9% | 78.2% | 76.7% | 78.3% | 76.4% | 75.8% |
| Healthcare Services | 17.7% | 17.9% | 19.3% | 17.7% | 19.6% | 19.4% |
| Retailing | — | 3.2% | 3.3% | 3.4% | 3.6% | 4.3% |
| Pharmaceuticals | 1.8% | 0.8% | 0.7% | 0.5% | 0.5% | 0.6% |
Allocation in May 2025change vs Apr 2025
- Pharmaceuticals & Biotechnology (26)75.8%▼ 0.6 pts
- Healthcare Services (8)19.4%▼ 0.1 pts
- Retailing (1)4.3%▲ 0.7 pts
Cash and debt
The share of the portfolio not in shares: cash and net receivables, money-market instruments and bonds, as disclosed each month. Cash can dip below zero when payables, often on derivative positions, exceed it. A change here describes what the fund did; it is not a signal.
Cash & debt, May 2025
1.4%
▲ 1.1 pts vs Apr 2025
- Cash alone
- 1.4%
- cash and net receivables
- A year earlier
- 1.6%
- May 2024 · now ▼ 0.2 pts
- Last 12 months
- 0.3% – 4.4%
- lowest to highest · record 5.9% in May 2021
History
Disclosed portfolio value by month, with the stocks the fund entered and exited against its previous disclosure. Every month is a link to that portfolio.